Antimicrobial Resistance in Common Respiratory Pathogens of Chronic Bronchiectasis Patients: A Literature Review

Antimicrobial Resistance in Common Respiratory Pathogens of Chronic Bronchiectasis Patients: A Literature Review

Non-cystic fibrosis bronchiectasis is a chronic disorder in which immune system dysregulation and impaired airway clearance cause mucus accumulation and consequent increased susceptibility to lung infections. The presence of pathogens in the lower respiratory tract causes a vicious circle resulting...

Full description

Bibliographic Details
Main Authors:	Riccardo Inchingolo, Chiara Pierandrei, Giuliano Montemurro, Andrea Smargiassi, Franziska Michaela Lohmeyer, Angela Rizzi
Format:	Article
Language:	English
Published:	MDPI AG 2021-03-01
Series:	Antibiotics
Subjects:	non-cystic fibrosis bronchiectasis multidrug-resistant (MDR) pathogens <i>Pseudomonas aeuriginosa</i> antimicrobial resistance (AMR) inhaled antibiotic macrolides
Online Access:	https://www.mdpi.com/2079-6382/10/3/326

Similar Items

Bronchiectasis
by: A G Chuchalin
Published: (2017-03-01)

Multidrug-resistant Pseudomonas aeruginosa is predisposed to lasR mutation through up-regulated activity of efflux pumps in non-cystic fibrosis bronchiectasis patients
by: Fengming Ding, et al.
Published: (2022-07-01)

Pathogenesis, imaging and clinical characteristics of CF and non-CF bronchiectasis
by: Schäfer, Jürgen, et al.
Published: (2018)

Impacts of Nontuberculous Mycobacteria Isolates in Non-cystic Fibrosis Bronchiectasis: A 16-Year Cohort Study in Taiwan
by: Chun-Yu Lin, et al.
Published: (2022-04-01)

Antimicrobial Resistance of <i>Staphylococcus</i> spp. from Human Specimens Submitted to Diagnostic Laboratories in South Africa, 2012–2017
by: Themba Titus Sigudu, et al.
Published: (2024-09-01)

Impact of concomitant nontuberculous mycobacteria and Pseudomonas aeruginosa isolates in non-cystic fibrosis bronchiectasis
by: Hsieh MH, et al.
Published: (2018-08-01)

Exacerbation Prevention and Management of Bronchiectasis
by: Joon Young Choi
Published: (2023-07-01)

Isolation, optimization and molecular characterization of lipase producing bacteria from contaminated soil
by: Oluwaseye I Ilesanmi, et al.
Published: (2020-07-01)

South African Thoracic Society position statement on the management of non-cystic fibrosis bronchiectasis in adults: 2023
by: A Goolam-Mahomed, et al.
Published: (2023-08-01)

Comparative microbiome analysis in cystic fibrosis and non-cystic fibrosis bronchiectasis.
by: Heryk Motta, et al.
Published: (2024-05-01)

Nuevos antibióticos inhalados y formas de administración
by: Luis Máiz Carro, et al.
Published: (2020-07-01)

Safety and Efficacy of Devices Delivering Inhaled Antibiotics among Adults with Non-Cystic Fibrosis Bronchiectasis: A Systematic Review and a Network Meta-Analysis
by: Sofia Tejada, et al.
Published: (2022-02-01)

Oxygen Limitation Enhances the Antimicrobial Activity of Fosfomycin in Pseudomonas aeruginosa Following Overexpression of glpT Which Encodes Glycerol-3-Phosphate/Fosfomycin Symporter
by: Hidetada Hirakawa, et al.
Published: (2018-08-01)

A Metagenomic approach to characterize temperate bacteriophage populations from cystic fibrosis and non-cystic fibrosis bronchiectasis patients
by: Mohammad Adnan Tariq, et al.
Published: (2015-02-01)

Clinical Pharmacology of Bacteriophage Therapy: A Focus on Multidrug-Resistant <em>Pseudomonas aeruginosa</em> Infections
by: Dana Holger, et al.
Published: (2021-05-01)

Fibrosis quística: Diagnóstico tardío en el adulto presentación de caso Delayed diagnosis of the cystic fibrosis in adulthood: A case report
by: Mireya Fernández Fernández, et al.
Published: (2010-06-01)

Activity of Delafloxacin and Comparator Fluoroquinolones against Multidrug-Resistant <i>Pseudomonas aeruginosa</i> in an In Vitro Cystic Fibrosis Sputum Model
by: Vaughn D. Craddock, et al.
Published: (2023-06-01)

Genomic and Antimicrobial Surveillance of <i>Campylobacter</i> Population in Italian Poultry
by: Francesca Marotta, et al.
Published: (2023-07-01)

Non-antimicrobial airway management of non-cystic fibrosis bronchiectasis
by: Ashley M. Egan, et al.
Published: (2018-01-01)

Isolation and Characterization of Colistin-Resistant <i>Enterobacteriaceae</i> from Foods in Two Italian Regions in the South of Italy
by: Rosa Fraccalvieri, et al.
Published: (2025-01-01)

Antimicrobial resistance of clinical bacterial isolates according to the WHO’s AWaRe and the ECDC-MDR classifications: the pattern in Ghana’s Bono East Region
by: Williams Walana, et al.
Published: (2023-12-01)

Antimicrobial Susceptibility of <i>Streptococcus suis</i> Isolated from Diseased Pigs in Thailand, 2018–2020
by: Kamonwan Lunha, et al.
Published: (2022-03-01)

Response to inhaled ceftazidime in patients with non‐cystic fibrosis bronchiectasis and chronic bronchial infection unrelated to Pseudomonas aeruginosa
by: Vanessa Riveiro, et al.
Published: (2022-11-01)

Safety and microbiological activity of phage therapy in persons with cystic fibrosis colonized with Pseudomonas aeruginosa: study protocol for a phase 1b/2, multicenter, randomized, double-blind, placebo-controlled trial
by: Pranita D. Tamma, et al.
Published: (2022-12-01)

Utilization of Inhaled Antibiotics in Pediatric Non-Cystic Fibrosis Bronchiectasis: A Comprehensive Review
by: Maria Tsouprou, et al.
Published: (2025-02-01)

Cystic fibrosis modulator therapy can reverse cystic bronchiectasis
by: Peter G. Middleton, et al.
Published: (2023-07-01)

Pulmonary Delivery of Antibiotics to the Lungs: Current State and Future Prospects
by: Yahya H. Dallal Bashi, et al.
Published: (2025-01-01)

Multidrug Resistance (MDR): A Widespread Phenomenon in Pharmacological Therapies
by: Alessia Catalano, et al.
Published: (2022-01-01)

Despite huge investment to contain AMR, recent reports of increased occurrence of superbugs are terrifying
by: BH Gulumbe
Published: (2018-10-01)

Diffuse Pan Bronchiolitis Presenting with Bronchiectasis: A Case Report
by: Swathi Karanth M. P, et al.
Published: (2019-01-01)

Surveillance of Antimicrobial Resistance of <i>Escherichia coli</i> Isolates from Intestinal Contents of Dairy and Veal Calves in the Veneto Region, Northeaster Italy
by: Laura Bortolami, et al.
Published: (2024-05-01)

Epidemiology of bronchiectasis at a single center in Japan: a retrospective cohort study
by: Kazuki Hashimoto, et al.
Published: (2024-10-01)

Changing epidemiology of non-cystic fibrosis bronchiectasis
by: Semiha Bahçeci, et al.
Published: (2016-02-01)

Antibiotic resistance profiles and associated factors of Pseudomonas Infections among patients admitted to large tertiary care hospital from a developing country
by: Sara Shbaita, et al.
Published: (2023-12-01)

Impact of Antipseudomonal Antibiotics in Patients with Bronchiectasis Who Experienced Exacerbation or Developed Pneumonia: A Nationwide Study in Japan
by: Akihiko Hagiwara, et al.
Published: (2024-12-01)

Microbiological profile of sputum in stable adult patients with bronchiectasis in the Dnipro region of Ukraine
by: K. Yu. Gashynova, et al.
Published: (2020-10-01)

Characterization of Streptococcus pneumoniae Macrolide Resistance and Its Mechanism in Northeast China over a 20-Year Period
by: Xiuzhen Zhou, et al.
Published: (2022-10-01)

Evaluation of Antibiotic Resistance Mechanisms in Gram-Positive Bacteria
by: Pratiksing Rajput, et al.
Published: (2024-12-01)

Epidemiology and outcomes of multidrug-resistant bacterial infection in non-cystic fibrosis bronchiectasis
by: Chih-Hao Chang, et al.
Published: (2024-02-01)

The Building Blocks of Antimicrobial Resistance in Pseudomonas aeruginosa: Implications for Current Resistance-Breaking Therapies
by: R. Frèdi Langendonk, et al.
Published: (2021-04-01)